Sort   by:  
 Page size 
UnknownMulticenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.
Not available
S-EPMC6209089 | biostudies-literature
UnknownRelationship of established risk factors with breast cancer subtypes.
Not available
S-EPMC8446564 | biostudies-literature
UnknownAssessment of barriers to pancreatic cancer surveillance in high-risk individuals.
Not available
S-EPMC12511838 | biostudies-literature
ProteomicsCardiotoxocity of Cancer Therapy Biomarkers
We used 3-dimensional proteomic profiling to discover new biomarkers associated with doxorubicin and trastuzumab-induced cardiac dysfunction.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2016-04-26 | MSV000079676 | MassIVE
UnknownA Population-Based Study of Genes Previously Implicated in Breast Cancer.
Not available
S-EPMC8127622 | biostudies-literature
UnknownContribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
Not available
S-EPMC7735769 | biostudies-literature
UnknownIdentification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Not available
S-EPMC4962376 | biostudies-literature
UnknownTailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Not available
S-EPMC6193457 | biostudies-literature
UnknownCommon genetic variants and modification of penetrance of BRCA2-associated breast cancer.
Not available
S-EPMC2965747 | biostudies-literature
UnknownNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Not available
S-EPMC4630206 | biostudies-literature
Sort   by:  
 Page size